Home/SEC 13D/G/ENTASEC 13D/GENTA - Enanta Pharmaceuticals, Inc. - SEC Filing Update (14-AUG-2026) | ThinkSabio - Stocks Simplified$ENTA$13.44▼ -6.73% YTDHealthcareAug 14, 2026 · ThinkSabio BlogSEC Filing Update: #ENTA Enanta Pharmaceuticals, Inc. : $13.44 Sector: Healthcare | YTD: 🔽 -6.73% The SEC disclosed Today (14-AUG-2026) that FARALLON CAPITAL MANAGEMENT LLC has DECREASED #ENTA Shares by -15.80% 🔴 * Previous Holdings: 2.87M Shares * Current Holdings: 2.42M Shares * Decrease -453.66K * Decreased (%)-15.80% * Ownership: 8.3% https://www.thinksabio.com/reports/isr/ENTA Institutional ownership in #ENTA has been steadily rising over the past 4 quarters in Shares: Q2 2025: 18.42M Q3 2025: 18.99M Q4 2025: 26.39M Q1 2026: 26.77M The quarterly average prices of #ENTA: Q3 2025: $7.99 Q4 2025: $12.64 Q1 2026: $13.40 Share this post🔗Copy LinkMore filings for $ENTAENTA - Enanta Pharmaceuticals, Inc. - SEC Filing Update (14-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 14, 2026💬 Comments Loading comments…Leave a commentPost Comment← All PostsMore SEC 13D/G